Singh, Siddharth;
Ananthakrishnan, Ashwin N;
Nguyen, Nghia H;
Cohen, Benjamin L;
Velayos, Fernando S;
Weiss, Jennifer M;
Sultan, Shahnaz;
Siddique, Shazia M;
Adler, Jeremy;
Chachu, Karen A.
Biomarkers are used frequently for noninvasive monitoring and treatment decision making in the management of patients with ulcerative colitis (UC). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the managemen...
Fuxman, Claudia;
Sicilia, Beatriz;
Linares, María Eugenia;
García-López, Santiago;
Sueyro, Ramiro González;
González-Lamac, Yago;
Zabana, Yamile;
Hinojosa, Joaquín;
Barreiro-de Acosta, Manuel;
Balderramo, Domingo;
Balfour, Deborah;
Bellicoso, Maricel;
Daffra, Pamela;
Morelli, Daniela;
Orsi, Marina;
Rausch, Astrid;
Ruffinengo, Orlando;
Torok, Martín;
Sambuellir, Alicia;
Novillos, Abel;
Gomollónt, Fernando;
Paula, Juan Andrés De.
Ulcerative colitis (UC) is a chronic inflammatory disease that compromises the colon, affecting the quality of life of individuals of any age. In practice, there is a wide spectrum of clinical situations. The advances made in the physio pathogenesis of UC have allowed the development of new, more effecti...
Evidence-based recommendations on upadacitinib (Rinvoq) for treating moderately to severely active ulcerative colitis in adults.
Commercial arrangement
There is a simple discount patient access scheme for upadacitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. ...
This guideline covers the management of ulcerative colitis in children, young people and adults. It
aims to help professionals to provide consistent high-quality care and it highlights the importance
of advice and support for people with ulcerative colitis....
Ulcerative colitis (UC) is a chronic disease affecting the large intestine, with an increasing incidence worldwide. Nearly 1 million individuals each in the United States and Europe are affected by this condition and many more globally. Over the past decade, since the publication of the last guideline fr...
Nguyen, GC;
Seow, CH;
Maxwell, C;
Huang, V;
Leung, Y;
Jones, J;
Leontiadis, GI;
Tse, F;
Mahadevan, U;
van der Woude, CJ.
"BACKGROUND & AIMS:
The management of inflammatory bowel disease (IBD) poses a particular challenge during pregnancy because the health of both the mother and the fetus must be considered.
METHODS:
A systematic literature search identified studies on the management of IBD during pregnancy. The quality o...
Immunosuppressive Agents/administration & dosage,
Colitis, Ulcerative,
Crohn Disease,
Drug Substitution,
Gastroenterology,
Maternal Health Services,
Preconception Care,
Pregnancy Complications,
Risk Assessment,
Risk Factors,
Treatment Outcome,
Inflammatory Bowel Diseases,
Crohn Disease/diagnosis,
Crohn Disease/therapy,
Pregnancy Complications/diagnosis,
Pregnancy Complications/therapy,
Immunosuppressive Agents/adverse effects,
Colitis, Ulcerative/diagnosis,
Colitis, Ulcerative/therapy
Bressler, B;
Marshall, J. K;
Bernstein, C. N;
Bitton, A;
Jones, J;
Leontiadis, G. I;
Panaccione, R;
Steinhart, A. H;
Tse, F;
Feagan, B.
BACKGROUND & AIMS:: The medical management of ulcerative colitis (UC) has improved through the development of new therapies and novel approaches that optimize existing drugs. Previous Canadian consensus guidelines addressed the management of severe UC in the hospitalized patient. We now present consensu...
Los objetivos de la Guía son: 1. Establecer recomendaciones basadas en las pruebas disponibles, para el tratamiento de inducción en el brote grave de colitis ulcerativa 2. Establecer recomendaciones para el tratamiento de inducción en el brote leve- moderado de colitis ulcerativa 3. Establecer recomen...
This guideline covers using colonoscopy to check for signs of bowel cancer in people aged 18 and over with ulcerative colitis or Crohn’s disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to prevent cancer and prolong life by offering advice on identifying early b...
